FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 349:817-818 August 21, 2003 Number 8 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article PubMed Citation

To the Editor: Magnetic resonance imaging is increasingly used to avoid the radiation used in computed tomographic scanning. Gadolinium contrast medium allows vascular imaging without the nephrotoxic effects associated with conventional contrast material.¹

A 62-year-old man with suspected renal-artery stenosis underwent magnetic resonance angiography (MRA) after receiving 40 ml of gadolinium (Omniscan, Amersham Health). Analysis of a blood sample obtained immediately after the MRA study revealed a plasma calcium level of only 4.4 mg per deciliter (normal range, 8.8 to 10.6). Six hours later, his calcium level was 7.2 mg per deciliter. The patient had no symptoms, and Chvostek's and . . . [Full Text of this Article]

Related Letters:

More on Pseudohypocalcemia and Gadolinium-Enhanced MRI
Prince M. R., Choyke P. L., Knopp M. V., Doorenbos C. J., Koster K., van Wijnen M.
Extract | Full Text | PDF  
N Engl J Med 2004; 350:87-88, Jan 1, 2004. Correspondence

This article has been cited by other articles:

• Gandhi, M. J., Narra, V. R., Brown, J. J., Guo, A., Grosu, D. S., Parvin, C. A., Scott, M. G. (2008). Clinical and Economic Impact of Falsely Decreased Calcium Values Caused by Gadoversetamide Interference. Am. J. Roentgenol. 190: W213-W217 [Abstract] [Full Text]  
• Brown, J. J., Hynes, M. R., Wible, J. H. Jr. (2007). Measurement of Serum Calcium Concentration After Administration of Four Gadolinium-Based Contrast Agents to Human Volunteers. Am. J. Roentgenol. 189: 1539-1544 [Abstract] [Full Text]  
• Mark, P. B., Mazonakis, E., Shapiro, D., Spooner, R. J., Stuart C. Rodger, R. (2005). Pseudohypocalcaemia in an elderly patient with advanced renal failure and renovascular disease. Nephrol Dial Transplant 20: 1499-1500 [Full Text]  
• Decupere, M., Ooms, V., Oyen, R., Kuypers, D. R. J., Claes, K. (2005). Artifactual hypocalcaemia after intravenous administration of gadodiamide (Omniscan(R)). Nephrol Dial Transplant 20: 1516-1517 [Full Text]  
• Kang, H. P., Scott, M. G., Joe, B. N., Narra, V., Heiken, J., Parvin, C. A. (2004). Model for Predicting the Impact of Gadolinium on Plasma Calcium Measured by the o-Cresolphthalein Method. Clin. Chem. 50: 741-746 [Abstract] [Full Text]  
• Prince, M. R., Choyke, P. L., Knopp, M. V., Doorenbos, C. J., Koster, K., van Wijnen, M. (2004). More on Pseudohypocalcemia and Gadolinium-Enhanced MRI. NEJM 350: 87-88 [Full Text]